^

Original-Research: Cenit AG - von GBC AG

Einstufung von GBC AG zu Cenit AG

Unternehmen: Cenit AG

ISIN: DE0005407100

Anlass der Studie: Research Comment

Empfehlung: BUY

Kursziel: 18,70 EUR

Kursziel auf Sicht von: 31.12.2023

Letzte Ratingänderung:

Analyst: Cosmin Filker, Marcel Goldmann

9M 2022: Growth course continued; Earnings increase despite special

effects; GBC earnings estimates slightly adjusted; Target price: EUR18.70

(previously: EUR19.00); BUY rating

 

In the past third quarter of 2022, CENIT AG achieved a significant increase

in sales revenues of 31.0 % to EUR 41.95 million (PY: EUR 32.04 million), thus

significantly accelerating the growth dynamics of the first two quarters of

the year. However, a significant part of the growth has an inorganic

origin. This is because the acquired ISR Information Products AG (ISR for

short) has been contributing to the group's revenues since June 2022. In

the third quarter, the inorganic sales contribution amounted to EUR 5.94

million, which means that CENIT AG achieved organic sales growth of 12.4%.

Over the first nine months, the increase in sales was 11.5% to EUR 115.86

million (previous year: EUR 103.96 million). Adjusted for ISR sales totalling

EUR 7.97 million, organic growth was 3.8%.

 

Separated according to the individual revenue segments, the

disproportionate increase in consulting revenues (+35.4%) is again evident,

while proprietary software revenues (+6.5%) and third-party software

revenues (+1.7%) show a significantly lower growth dynamic. Since the

business of the newly acquired ISR consists largely of consulting services,

the inorganic effect can be found in particular in the consulting revenues.

In this sales segment, CENIT AG is also benefiting from high demand from

the aerospace sector and, in principle, from catch-up effects after

consulting and service sales had each declined sharply during the corona

pandemic.

 

Total revenues of EUR 69.52 million (previous year: EUR 68.35 million) for the

first nine months of 2022 consist of recurring revenues, which account for

60.0% of the total. There is therefore good planning predictability for the

subsequent reporting periods.

 

Compared to the 11.5% increase in sales, CENIT AG reports a

disproportionately low increase in EBIT of 6.0% to EUR 2.58 million (previous

year: EUR 2.44 million) and thus a slightly lower EBIT margin of 2.2%

(previous year: 2.3%). Although the newly acquired ISR contributed EUR 1.00

million to the group EBIT, this was offset by ancillary acquisition costs

of EUR 0.16 million. In addition, CENIT AG had received short-time working

benefits of around EUR 1.3 million in the previous year, which led to a

corresponding reduction in personnel expenses. Finally, research allowances

were reduced by around EUR 0.50 million compared to the previous year.

Against the background of the above-mentioned effects, their EBIT

development can be considered a success.

 

CENIT's management has confirmed its guidance for the current business

year, subject to the express proviso that the economic and

industry-specific conditions do not deteriorate significantly. The company

continues to expect consolidated sales of around EUR 170 million and a

consolidated EBIT of around EUR 9.0 million. Based on this, the company would

have to generate revenues of around EUR 54 million and an EBIT of around EUR

6.4 million in the fourth quarter of 2022, which would be equivalent to a

significant increase in revenues and earnings compared to the final quarter

of the previous year.

 

However, the Executive Board is confident that it will be able to achieve

what it has forecast. On the one hand, the inorganic contributions to

turnover and earnings should contribute significantly to the expansion of

the key operating figures expected for the fourth quarter. On the other

hand, foreseeable new customers could already lead to an increase in

proprietary software sales, which should be particularly relevant for the

expected increase in earnings.  In our previous forecasts (see study of

04.08.2022) we were slightly above the company's guidance, especially on

the earnings side. We are taking the current business development as an

opportunity to reduce our earnings forecasts for the current financial year

only. We now expect an EBIT of EUR 8.70 million (previously: EUR 9.42 million).

Our forecasts for the coming financial years remain unchanged.

 

Within the framework of the adjusted DCF valuation model, we have

determined a new target price of EUR 18.70 (previously: EUR 19.00). Although

the slight reduction in the target price is slightly due to the lowering of

the 2022 earnings forecasts, the main reason for this is the further

increase in the risk-free interest rate to 1.50% (previously: 1.25%). We

continue to assign a rating of BUY.

 

 

Die vollständige Analyse können Sie hier downloaden:

http://www.more-ir.de/d/25805.pdf

Kontakt für Rückfragen

++++++++++++++++

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,6a,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:

http://www.gbc-ag.de/de/Offenlegung.htm

+++++++++++++++

Date (time) of completion: 07/11/2022 (08:07 am)

Date (Time) first distribution: 07/11/2022 (09:30 am)

-übermittelt durch die EQS Group AG.-

Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.

Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung

oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

°